We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Experimental peri-implantitis around titanium implants with a chemically modified surface with a monolayer of multi-phosphonate molecules: a preclinical in vivo investigation.
- Authors
Sanz-Esporrin, J.; Di Raimondo, R.; Pla, R.; Luengo, F.; Vignoletti, F.; Núñez, J.; Antonoglou, G. J.; Blanco, J.; Sanz, M.
- Abstract
Objectives: The purpose of this experimental in vivo investigation was to evaluate the influence of modifying the implant surface by adding a monolayer of multi-phosphonate molecules on the development of experimental peri-implantitis. Material and methods: Eight beagle dogs received 5 tests and 5 control implants each following a split-mouth design 3 months after premolar and molar extraction. On the most mesial implant of each side, a 3-mm buccal dehiscence was artificially created. Experimental peri-implantitis was induced by silk ligatures over a 4-month period; after ligature removal, peri-implantitis was left to progress for another 4 months without plaque control. Clinical, histological, and radiographic outcomes were evaluated. Results: Radiographically, both implant groups showed a similar bone loss (BL) at the end of the induction and progression phases. BL measured on the histological sections of the test and control groups was 3.14 ± 0.42 mm and 3.26 ± 0.28 mm, respectively; the difference was not statistically significant (p > 0.05). The remaining buccal bone to implant contact (bBIC) percentage of the test and control groups was 59.38 ± 18.62 and 47.44 ± 20.46%, respectively; the difference, however, was not statistically significant (p > 0.05). Bone loss observed at dehiscent sites compared to non-dehiscent ones showed no statistically significant difference (p > 0.05). Conclusions: Addition of a monophosphonate layer to a moderately rough implant surface did not affect development of experimental peri-implantitis. Clinical relevance: Influence of implant surface on peri-implantitis may condition implant selection by the clinician, especially on patients with disease risk factors. In that sense, monophosphate layer implants do not show higher peri-implantitis risk than control implants.
- Subjects
PERI-implantitis; DISEASE risk factors; MONOMOLECULAR films; BEAGLE (Dog breed); MEDICAL personnel; PHOSPHONATES; SILK fibroin
- Publication
Clinical Oral Investigations, 2021, Vol 25, Issue 6, p3789
- ISSN
1432-6981
- Publication type
Article
- DOI
10.1007/s00784-020-03708-4